Chris Holland

3.7k citations
25 papers · 929 indexed · 1 hit paper · h-index 9
Topics
Ocular Oncology and Treatments (10 papers)Acute Lymphoblastic Leukemia research (8 papers)CAR-T cell therapy research (6 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Chris Holland

23 papers receiving 881 citations

Hit Papers

Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager...20142026201820222014100200300400

Peers

Chris Holland
Comparison fields: 5 of 67
  • Oncology 603
  • Public Health, Environmental and Occupational Health 351
  • Immunology 210
  • Pathology and Forensic Medicine 188
  • Hematology 176
Replace Hun Ju Lee with:
Hun Ju Lee United States
Mark Stewart United States
William Stevenson Australia
S. Krishnaswami United States
Michael Dickinson Australia
Barbara Withers Australia
Kazuyoshi� Ishii Japan
Elisa Thomas Norway
Hildur Helgadóttir Sweden
Denise Williams United States
Chris Holland relative to Hun Ju Lee United States Hun Ju Lee's profile →
Citations per field
00.5×2.6×
Hun Ju Lee · 1×
Citations per year

Countries citing papers authored by Chris Holland

Since Specialization
Citations

This map shows the geographic impact of Chris Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Holland more than expected).

Fields of papers citing papers by Chris Holland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Holland. The network helps show where Chris Holland may publish in the future.

Co-authorship network of co-authors of Chris Holland

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Holland. A scholar is included among the top collaborators of Chris Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Holland. Chris Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 22
2 1
3 1
4 3
5 8
6 13
7 1
8 4
9 53
10 6
11 6
12 115
13 6
14 14
15 0
16 3
17 26
18 0
19 121
20 4

About Chris Holland

Chris Holland is a scholar working on Ophthalmology, Oncology and Immunology, having authored 25 papers that have together received 929 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (603 citations), Hematology (176 citations) and Public Health, Environmental and Occupational Health (351 citations). Chris Holland has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Geoff Lockett, Ian Blackman, Gerhard Zugmaier, Max S. Topp, Nicola Gökbuget, Ralf C. Bargou, Christoph Faul, Matthias Stelljes, Albrecht Reichle and Andreas Viardot. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026